| NDC Code | 43742-2261-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-2261-1) |
|---|
| Product NDC | 43742-2261 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Addiclenz |
|---|
| Non-Proprietary Name | Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Arsenicum Album, Beta Vulgaris, Bisphenol A, Boldo, Chelidonium Majus, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Petroselinum Sativum, Phosphoricum Acidum, Selenium Metallicum, Taraxacum Officinale, Zincum Metallicum |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20250311 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BETA VULGARIS WHOLE; BISPHENOL A; CHELIDONIUM MAJUS WHOLE; COBALT; COPPER; FORMALDEHYDE SOLUTION; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM WHOLE; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE, UNSPECIFIED FORM; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE |
|---|
| Strength | 12; 30; 30; 3; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC] |
|---|